AI Drug Discovery

Enveda, a biotech startup that makes use of AI to find new medication within the pure world, has raised a $311 million Collection E at a $2 billion valuation. The recent funding, which was led by Catalio Capital Administration, with participation from Iconiq and others, doubles the valuation Enveda achieved 12 months in the past….